Name: genetic testing: care, consent and liability
Price: 153050.00 CLP
Availability: InStock
Author: neil f. sharpe, ronald f. carter
ISBN: 9780471649878

portada genetic testing: care, consent and liability

genetic testing: care, consent and liability

Formato

Libro Físico

Editorial

wiley-liss

Autor

neil f. sharpe, ronald f. carter

N° páginas

624.00

ISBN

0471649872

ISBN13

9780471649878

Categorías

Derecho médico y sanitario

genetic testing: care, consent and liability

Neil F. Sharpe, Ronald F. Carter (Autor) · wiley-liss · Libro Físico

Libro Nuevo Importado *

Envío: 11 a 15 días háb.

$ 306.100$ 153.050

-50%

* Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 52 unidades

$ 153.050

Se enviará desde nuestra bodega entre el Miércoles 15 de Abril y el Martes 21 de Abril

Agregar a lista de deseos

Reseña del libro "genetic testing: care, consent and liability"

this book provides the only such concise, clearly written, practical treatment of the genetic, clinical, legal, and ethical issues confronting health care professionals. it identifies protocols and policies that constitute reasonable standards of care. it also performs the invaluable job of explaining the legal framework that surrounds genetic testing to help establish policies and protocols that will protect health care professionals from allegations of malpractice. moreover, the authors describe physician-patient relationships and how the medical genetics revolution is affecting it. it is presented in an easy-to-use format, with summaries as well as medical and legal case studies to illustrate important points. the first part looks at the patients expectations, doctor-patient communication, psychological aspects, medical malpractice, family history evaluations, and referral to medical geneticists/genetic counselors. the next section examines genetic screening, including prenatal, neonatal, carrier, and susceptibility testing. finally, the authors discuss diagnosis, risk assessment, confidentiality, and clinical/legal issues related to follow-up.